SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-001628
Filing Date
2024-01-05
Accepted
2024-01-05 08:08:19
Documents
14
Period of Report
2024-01-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2333797d1_8k.htm   iXBRL 8-K 32814
2 EXHIBIT 99.1 tm2333797d1_ex99-1.htm EX-99.1 11747
6 GRAPHIC tm2333797d1_ex99-1img001.jpg GRAPHIC 5687
  Complete submission text file 0001104659-24-001628.txt   230793

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA twst-20240105.xsd EX-101.SCH 3036
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE twst-20240105_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE twst-20240105_pre.xml EX-101.PRE 22373
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2333797d1_8k_htm.xml XML 3201
Mailing Address 681 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 681 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 800-719-0671
Twist Bioscience Corp (Filer) CIK: 0001581280 (see all company filings)

IRS No.: 462058888 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-38720 | Film No.: 24514480
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)